Group 1E: Lung Metastasis, Tumor Immune Microenvironment, Triple Negative Breast Cancer

Thursday, Sept 15
10:00 am – 11:30 am Eastern Time (US/New York)

Poster #1: 

Breast Tumor Cell Heme Metabolism Alters Macrophage Polarization and Function to Support Lung Metastasis

Poster author Michelle Williams, Ph.D. will attend this session

Poster #2:

Intratumoral Monocyte Differentiation as a Function of Macrophage-Niche Availability and Its Role in Sustaining the Intratumoral Macrophage Pool In TNBC

Mentor: Stephanie Walker, R.N.

Stephanie Walker was diagnosed in July 2015 with de novo MBC. A retired RN with close to 40 years of clinical practice and 3 years teaching in a Community College. Her experience has been pediatric and adult critical care working in level 1 trauma centers and critical access hospitals. The last 15 years of her nursing career were with Hospice care. She is a member of many organizations local and national based and a recipient of the Spirit to Impact award. She is also project lead on an initiative called BECOME (Black Experience of Clinical Trials and Opportunities of Meaningful Engagement), as part of the MBC Alliance. She is advocating for men and women in rural areas for equal access to quality healthcare, treatment modalities, and resources. She does not want anyone to feel alone, isolated, or defeated.

Twitter: @faceofstage4

Scientist: Jessica Christenson, Ph.D.

Jessica Christenson is a cancer biologist currently performing research at the University of Colorado Anschutz Medical Campus. For the past 13 years Jessica has made it her mission to discover more effective treatments for patients with breast cancer. In recent years her aims have shifted to focus exclusively on the study of metastatic disease. Jessica is currently investigating how the lung itself promotes the growth and survival of metastases in an effort to better understand ways in which to block metastatic progression and extend the survival and quality of life of patients with metastatic disease. In a project funded by a METAvivor Early Career Investigator Award, she is presently studying how lung-targeted therapies, such as those used to treated asthma and chronic inflammatory diseases, may be repurposed for use in metastatic patients, and while her primary research is focused on breast cancer, she has great hope that her discoveries will provide benefit for any patient with lung metastases. Like countless others, cancer has taken the lives of several of Jessica’s loved ones, and she is committed to making metastatic cancer a treatable and survivable condition.